Global Molecular Diagnostics Market US$ 10.5 Billion by 2021

Global Molecular Diagnostics Market US$ 10.5 Billion by 2021

According to a new market research report published by iHealthcareAnalyst, Inc., Molecular Diagnostics Market – Global Technologies and Applications Analysis and Forecast 2017-2021, the global molecular diagnostics market is estimated to reach US$ 9.5 Billion in 2020, expanding at a CAGR of 12.0% from 2017 to 2021.

Visit the Molecular Diagnostics Market – Global Technologies and Applications Analysis and Forecast 2017-2021 report at

As many molecular techniques and/or technologies such as PCR, FISH, NGS, and biochips have made their expected transitions into the clinical arena, molecular diagnostics has become an integral part of clinical applications such as genomics, proteomics, oncology, microbiology, blood screening, prenatal and newborn screening and women’s health. The global molecular diagnostics market report estimates the market size (Revenue US$ million – 2014 to 2021) and composition of this market and also forecasts growth trends (CAGR% – 2017 to 2021). It also covers the major companies operating in the market and provides detailed analysis of the different technologies and applications in the global market.

The global molecular diagnostics market is segmented as:

  1. Technology
    • Biochips and Microfluidics
    • Hybridization (ISH and FISH)
    • Mass Spectrometry
    • Next Generation Sequencing
    • Polymerase Chain Reaction
    • Transcription Mediated Amplification (TMA)
    • Others
  1. Application
    • Blood Screening
    • Genomics
    • Infectious Disease Testing
    • Microbiology
    • Oncology
    • Prenatal and Newborn Screening
    • Women’s Health
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.
    • Alere, Inc.
    • bioMérieux SA
    • Bio-Rad Laboratories, Inc.
    • Cepheid, Inc.
    • Danaher Corporation
    • Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Meridian Bioscience, Inc.
    • PerkinElmer, Inc.
    • Qiagen N.V.
    • Randox Laboratories, Ltd.
    • Siemens AG
    • Thermo Fisher Scientific, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]

2017-11-05T19:05:22+00:00 Categories: Press Releases|